Source: Molecular Neurobiology. Unidades: FFCLRP, FMRP
Subjects: DEPRESSÃO, HIPOCAMPO, INFLAMAÇÃO, SEROTONINA
ABNT
DIAS, Isabella Caroline da Silva et al. Indoleamine-2,3-dioxygenase/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes. Molecular Neurobiology, v. 53, n. 10, p. 6997-7009, 2016Tradução . . Disponível em: https://doi.org/10.1007/s12035-015-9617-0. Acesso em: 28 set. 2024.APA
Dias, I. C. da S., Carabelli, B., Ishii, D. K., Morais, H. de, Carvalho, M. C. de, Souza, L. E. R. de, et al. (2016). Indoleamine-2,3-dioxygenase/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes. Molecular Neurobiology, 53( 10), 6997-7009. doi:10.1007/s12035-015-9617-0NLM
Dias IC da S, Carabelli B, Ishii DK, Morais H de, Carvalho MC de, Souza LER de, Zanata SM, Brandão ML, Cunha TM, Ferraz AC, Cunha JM da, Zanoveli JM. Indoleamine-2,3-dioxygenase/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes [Internet]. Molecular Neurobiology. 2016 ; 53( 10): 6997-7009.[citado 2024 set. 28 ] Available from: https://doi.org/10.1007/s12035-015-9617-0Vancouver
Dias IC da S, Carabelli B, Ishii DK, Morais H de, Carvalho MC de, Souza LER de, Zanata SM, Brandão ML, Cunha TM, Ferraz AC, Cunha JM da, Zanoveli JM. Indoleamine-2,3-dioxygenase/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes [Internet]. Molecular Neurobiology. 2016 ; 53( 10): 6997-7009.[citado 2024 set. 28 ] Available from: https://doi.org/10.1007/s12035-015-9617-0